Inulin

Inulin is an unknown pharmaceutical. Inulin was first approved as Inulin and sodium chloride on 1982-01-01.

Download report

Favorite

Commercial

Therapeutic Areas

No data

Trade Name

FDA

EMA

No data

Drug Products

FDA

EMA

New Drug Application (NDA)

Abbreviated New Drug Application (ANDA)

Inulin

Tradename	Company	Number	Date	Products
INULIN AND SODIUM CHLORIDE	Iso-Tex Diagnostics	N-002282 DISCN	1982-01-01	1 products

Hide discontinued

Labels

FDA

EMA

No data

Indications

FDA

EMA

No data

Agency Specific

FDA

EMA

No data

Patent Expiration

No data

ATC Codes

V: Various drug classes in atc

— V04: Diagnostic agents

— V04C: Other diagnostic agents in atc

— V04CH: Renal function and ureteral injuries test diagnostic agents

— V04CH01: Inulin and other polyfructosans

HCPCS

No data

Clinical

Clinical Trials

130 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Patent ductus arteriosus	D004374	HP_0001643	Q25.0	1	5	5	1	4	15
Pancreatitis	D010195	EFO_0000278	K85	—	—	4	4	5	13
Premature obstetric labor	D007752		O60	2	3	2	3	3	11
Healthy volunteers/patients	—			3	—	—	2	1	6
Postoperative pain	D010149		G89.18	—	1	2	1	1	5
Ankylosing spondylitis	D013167	EFO_0003898	M45	—	—	1	1	—	2
Colorectal neoplasms	D015179			1	—	—	1	—	2
Hemorrhage	D006470	MP_0001914	R58	—	—	1	1	—	2
Inflammation	D007249			1	—	—	1	—	2
Premature birth	D047928	EFO_0003917	O60	—	1	—	1	—	2

Show 10 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Squamous cell carcinoma of head and neck	D000077195			—	2	1	—	—	3
Cardiovascular diseases	D002318	EFO_0000319	I98	1	1	1	—	—	2
Squamous cell carcinoma	D002294			—	1	1	—	—	2
Cerebral intraventricular hemorrhage	D000074042			1	1	1	—	—	2
Gouty arthritis	D015210			—	—	1	—	—	1
Langerhans-cell histiocytosis	D006646		C96.6	—	1	1	—	—	1
Pain	D010146	EFO_0003843	R52	—	—	1	—	—	1
Renal colic	D056844	EFO_1001412	N23	—	—	1	—	—	1
Alzheimer disease	D000544	EFO_0000249	F03	—	—	1	—	—	1
Congenital heart defects	D006330	HP_0001627	Q24.9	—	—	1	—	—	1

Show 2 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Prostatic neoplasms	D011471		C61	3	3	—	—	—	4
Regional blood flow	D012039			—	1	—	—	1	2
Adenocarcinoma	D000230			—	1	—	—	—	1
Covid-19	D000086382		U07.1	1	1	—	—	—	1
Hypertension	D006973	EFO_0000537	I10	1	1	—	—	—	1
Stroke	D020521	EFO_0000712	I63.9	1	1	—	—	—	1
Obstructive sleep apnea	D020181	EFO_0003918	G47.33	1	1	—	—	—	1
Dental pins	D003772			—	1	—	—	—	1
Tachycardia	D013610	HP_0001649	R00.0	1	1	—	—	—	1
Orthostatic intolerance	D054971			1	1	—	—	—	1

Show 11 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Asthma	D001249	EFO_0000270	J45	1	—	—	—	—	1
Ovarian neoplasms	D010051	EFO_0003893	C56	1	—	—	—	—	1
Esophageal neoplasms	D004938		C15	1	—	—	—	—	1
Pure autonomic failure	D054970			1	—	—	—	—	1
Orthostatic hypotension	D007024		I95.1	1	—	—	—	—	1
Drug interactions	D004347			1	—	—	—	—	1
Breast neoplasms	D001943	EFO_0003869	C50	1	—	—	—	—	1
Triple negative breast neoplasms	D064726			1	—	—	—	—	1
Male breast neoplasms	D018567			1	—	—	—	—	1
Gout	D006073	EFO_0004274	M10	1	—	—	—	—	1

Show 1 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Nephrogenic diabetes insipidus	D018500		N25.1	—	—	—	—	1	1
Endoscopic retrograde cholangiopancreatography	D002760			—	—	—	—	1	1
Migraine disorders	D008881	EFO_0003821	G43	—	—	—	—	1	1
Acute necrotizing pancreatitis	D019283			—	—	—	—	1	1
Dehydration	D003681		E86.0	—	—	—	—	1	1
Wounds and injuries	D014947		T14.8	—	—	—	—	1	1
Ocular physiological phenomena	D009799			—	—	—	—	1	1
Pancreaticoduodenectomy	D016577			—	—	—	—	1	1
Systemic inflammatory response syndrome	D018746	EFO_1001478	R65.10	—	—	—	—	1	1

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	INULIN
INN	—
Description	Inulins are a group of naturally occurring polysaccharides produced by many types of plants, industrially most often extracted from chicory. The inulins belong to a class of dietary fibers known as fructans. Inulin is used by some plants as a means of storing energy and is typically found in roots or rhizomes. Most plants that synthesize and store inulin do not store other forms of carbohydrate such as starch. In the United States in 2018, the Food and Drug Administration approved inulin as a dietary fiber ingredient used to improve the nutritional value of manufactured food products. Using inulin to measure kidney function is the "gold standard" for comparison with other means of estimating glomerular filtration rate.
Classification	Small molecule
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	OC[C@H]1O[C@H](O[C@]2(CO[C@]3(CO[C@]4(CO[C@]5(CO[C@]6(CO[C@]7(CO[C@]8(CO[C@]9(CO[C@]%10(CO[C@]%11(CO[C@]%12(CO[C@]%13(CO[C@]%14(CO[C@]%15(CO[C@]%16(CO[C@]%17(CO[C@]%18(CO[C@]%19(CO[C@]%20(CO[C@]%21(CO[C@]%22(CO[C@]%23(CO[C@]%24(CO[C@]%25(CO[C@]%26(CO[C@]%27(CO[C@]%28(CO[C@]%29(CO[C@]%30(CO[C@]%31(CO[C@]%32(CO[C@]%33(CO[C@]%34(CO[C@]%35(CO[C@]%36(CO[C@]%37(CO[C@]%38(CO)O[C@H](CO)[C@@H](O)[C@@H]%38O)O[C@H](CO)[C@@H](O)[C@@H]%37O)O[C@H](CO)[C@@H](O)[C@@H]%36O)O[C@H](CO)[C@@H](O)[C@@H]%35O)O[C@H](CO)[C@@H](O)[C@@H]%34O)O[C@H](CO)[C@@H](O)[C@@H]%33O)O[C@H](CO)[C@@H](O)[C@@H]%32O)O[C@H](CO)[C@@H](O)[C@@H]%31O)O[C@H](CO)[C@@H](O)[C@@H]%30O)O[C@H](CO)[C@@H](O)[C@@H]%29O)O[C@H](CO)[C@@H](O)[C@@H]%28O)O[C@H](CO)[C@@H](O)[C@@H]%27O)O[C@H](CO)[C@@H](O)[C@@H]%26O)O[C@H](CO)[C@@H](O)[C@@H]%25O)O[C@H](CO)[C@@H](O)[C@@H]%24O)O[C@H](CO)[C@@H](O)[C@@H]%23O)O[C@H](CO)[C@@H](O)[C@@H]%22O)O[C@H](CO)[C@@H](O)[C@@H]%21O)O[C@H](CO)[C@@H](O)[C@@H]%20O)O[C@H](CO)[C@@H](O)[C@@H]%19O)O[C@H](CO)[C@@H](O)[C@@H]%18O)O[C@H](CO)[C@@H](O)[C@@H]%17O)O[C@H](CO)[C@@H](O)[C@@H]%16O)O[C@H](CO)[C@@H](O)[C@@H]%15O)O[C@H](CO)[C@@H](O)[C@@H]%14O)O[C@H](CO)[C@@H](O)[C@@H]%13O)O[C@H](CO)[C@@H](O)[C@@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O

Identifiers

PDB	—
CAS-ID	9005-80-5
RxCUI	5924
ChEMBL ID	CHEMBL1201646
ChEBI ID	—
PubChem CID	24763
DrugBank	DB00638
UNII ID	—

Target

Agency Approved

No data

Alternate

No data

Variants

Clinical Variant

No data

Financial

No data

Trends

PubMed Central

Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data

Additional graphs summarizing 25,473 documents

View more details

Safety

Black-box Warning

No Black-box warning

Adverse Events

Top Adverse Reactions

Mock data
Subscribe for the real data

5,305 adverse events reported

View more details

Real-time Data on

Companies, Drugs, and Diseases

PharmaKB

MATERIALS

COMPANY